Practitioner Information
About OncoDNA
OncoDNA offers a unique and powerful combination of techniques (NGS of large gene panels and immunohistochemistry analyses, among others) for therapeutic decision-making. These tests are performed on liquid and/or solid biopsies, analysing relevant somatic or germline alterations. OncoDNA’s reporting platforms can integrate NGS results with IHC, MSI and TMB data to provide the Oncologist with an accurate clinical interpretation.
About Analyses
How long will the results take*?
OncoDEEP: 10 business days
OncoSTRAT&GO**: 10 business days
OncoSELECT: 10 business days
OncoFOLLOW**: 10 business day
*The times listed above do not include the time required to obtain the biopsy from local pathology nor the shipment of the biopsy to OncoDNA.
**OncoSTRAT&GO BRCA and OncoFOLLOW Personalised TAT is 15 business days.
Publication List
Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study - Frontiers in Oncology
Combination of solid and liquid biopsy genomic profiling for tumor heterogeneity characterization - ESMO
Tumor-biopsy stratification based on mTOR-pathway activity and functional mutations in the upstream genes PIK3CA and PTEN - Oncotarget
Genomic Profiling for Patients with Solid Tumors: A Single-Institution Experience - Annals of Clinical Oncology
The clinical impact of using complex molecular profiling strategies in routine oncology practice - Oncotarget
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy - Translational Cancer Research
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor - Oncotarget
A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma - Oncotarget
The combined analysis of solid and liquid biopsies provides additional clinical information to improve patient care - J. of Cancer Metastasis and Treatment
For more information
Genostics Australia is the distributor for OncoDNA in Australia and New Zealand.
For more information including publications, brochures, request forms, or to find out how to order a test, please call Genostics on +61 1300 282 482 or submit an online enquiry here.